Articles for October 2018

As part of a continuing series on Spring 2019 semester courses that relate to innovation and business law, this post spotlights the Iowa Medical Innovation Group.
            Precision medicine and genome editing-based therapies offer great promise but also come at great cost: one recently developed medicine, for example, costs $1,00,000 for a single dose.   Professor Anya Prince addressed the promise of genome editing and the issue of paying for it during
Subscribe to Articles